GaPP: A pilot randomised controlled trial of the efficacy of action of gabapentin for the management of chronic pelvic pain in women: study protocol

BMJ Open

Volumn 2, Issue 3, 2012, Pages

  Horne, Andrew W ^a   Critchley, Hilary O D ^a   Doust, Ann ^a   Fehr, Daniel ^b   Wilson, John ^c   Wu, Olivia ^d   Jack, S ^e   Porter, Maureen ^f   Lewis, Steff ^g   Bhattacharya, Siladitya ^f  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Universitäres Interdisziplinäres Kinderwunschzentrum Düsseldorf   (Germany)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^f UNIVERSITY OF ABERDEEN   (United Kingdom)

^g UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN; PLACEBO;

ARTICLE; CONCENTRATION LOSS; DIZZINESS; DRUG DOSE INCREASE; DRUG EFFICACY; FEMALE; HUMAN; MOOD CHANGE; MULTICENTER STUDY (TOPIC); PELVIS PAIN SYNDROME; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIDE EFFECT; SOMNOLENCE; UNITED KINGDOM;

EID: 84863686313     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2012-001297     Document Type: Article

References (16)

1. Latthe P, Latthe M, Say L, et al. WHO systematic review of prevalence of chronic pelvic pain: a neglected reproductive health morbidity. BMC Public Health 2006;6:177.
2. Daniels JP, Khan KS. Chronic pelvic pain in women. BMJ 2010;341:c4834.
3. Cheong Y, Stones WR. Chronic pelvic pain: aetiology and therapy. Best Pract Res Clin Obstet Gynaecol 2006;20:695-711. (Pubitemid 44507692)
4. Stones RW, Mountfield J. Interventions for treating chronic pelvic pain in women. Cochrane Database Syst Rev 2000;(4):CD000387.
5. Sator-Katzenschlager SM, Scharbert G, Kress HG, et al. Chronic pelvic pain treated with gabapentin and amitriptyline: a randomized controlled pilot study. Wien Klin Wochenschr 2005;117:761.
6. Wiffen PJ, McQuay HJ, Edwards JE, et al. Gabapentin for acute and chronic pain. Cochrane Database Syst Rev 2005;(3):CD005452.
7. Thabane L, Ma J, Chu R, et al. A tutorial on pilot studies: the what, why and how. BMC Med Res Methodol 2010;10:1.
8. Barbour RS. Focus groups. In: Bourgeault I, Dingwall R, de Vries R eds. The SAGE Handbook of Qualitative Methods in Health Research. London, UK: Sage Publications Ltd, 2010:327-52.
9. Melnikow J, Kiefe C. Patient compliance and medical research: issues in methodology. J Gen Intern Med 1994;9:96-105. http://www.nice.org.uk/aboutnice/ media/B52/A7/TAMethodsGuideUpdatedJune2008.pdf (Pubitemid 24059129)
10. National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal. NICE 2008. http://www.nice.org.uk/media/B52/A7/ TAMethodsGuideUpdatedJune2008.pdf
11. Dworkin RH, Turk DC, Peirce-Sandner S, et al. Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations. Pain 2010;149:177-93.
12. Temple R, Ellenberg SS. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues. Ann Intern Med 2000;133:455-63.
13. Ellenberg SS, Temple R. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 2: practical issues and specific cases. Ann Intern Med 2000;133:464-70.
14. Sculpher MJ, Claxton K, Drummond M, et al. Whither trial-based economic evaluation for health care decision making? Health Econ 2006;15:667-87.
15. Boyd KA, Fenwick E, Briggs A. Using an iterative approach to economic evaluation in drug development process. Drug Dev Res 2010;71:470-7.
16. Kelly AM. The minimum clinically significant difference in visual analogue scale pain score does not differ with severity of pain. Emerg Med J 2001;18:205-7.